The exact relationship between the MAPK pathway and RAS in the pathophysiology of DM disease remains to be explored, but this study suggests that the MAPK signaling pathway is important in the modulation of ACE and ACE2 expression and that the inhibition of MAPK signaling could effectively preclude high-glucose-induced kidney damage in tubular cells [64]. Here, ACE is linked to diabetes mellitus.